Sep 06, 2022 09:15 PM IST

Biocon sells 5.4% stake in arm Syngene International

According to bulk deal data available with the BSE, Biocon, the promoter of Syngene International, sold a total of 21,789,164 shares, amounting to a 5.4 percent stake, in the company.

Moneycontrol Selects: Top stories this evening

Our specially curated package of the most interesting articles to help you stay at the top of your game.

Biocon may sell part stake in Syngene in open market

The deal will most likely be at a discount of up to 5 %, CNBC Awaaz has said

Biocon says US FDA issued 11 observations each for firm's two sites in Bengaluru

These include multiple drug substance and drug product facilities and other support infrastructure at these sites.

CBI files charge sheet in Biocon case against five persons

The agency in its charge sheet filed on August 18 has alleged that the bribe payment was being paid to Joint Drug Controller S Eswara Reddy after clearance from associate vice president of Biocon Biologics L Praveen Kumar, they said.

These 3 stocks can give up to 15% return in short-term

The weekly expiry could keep the markets volatile as we have witnessed steady rise in open interest in 18,000 CE strike in the past few days while on the downside 17,800 PE strike has the highest open interest of more than 2,20,000 contracts which could act as immediate support from current levels.

Buy Biocon; target of Rs 362: Sharekhan

Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 362 in its research report dated July 28, 2022.

Biocon Consolidated June 2022 Net Sales at Rs 2,139.50 crore, up 21.52% Y-o-Y

Biocon Standalone June 2022 Net Sales at Rs 441.70 crore, up 15.42% Y-o-Y

Biocon net profit rises 71% to Rs 144 crore in June quarter

The company had posted a net profit of Rs 84 crore in the April-June quarter of the previous fiscal.

Kiran Mazumdar-Shaw wants a ‘tech fix’ for global lost luggage crisis

Kiran Mazumdar-Shaw called on the International Air Transport Association to look into the global ‘lost luggage crisis’ plaguing the aviation industry.

Bribery case part of ‘larger conspiracy’ to prevent me from being DCGI: S Eswara Reddy

A CBI court has rejected the bail pleas of Joint Drug Controller S Eswara Reddy and four others for allegedly taking a bribe to waive the phase-3 clinical trial of the Insulin Aspart injection of Biocon Biologics

CBI court to pronounce order in CDSCO bribery case today

The court will also give its order on an application to test voice samples of all the arrested in a bribery scandal reportedly involving a joint senior executive of Biocon Biologics.

CBI special court reserves S Eswara's bail application in bribery case

The CBI counsel today requested the special court for voice sampling of all the five accused.

Biocon Biologics' new manufacturing plant in Bengaluru gets EU certification

The manufacturing facility will enhance the company's capability to manufacture drug substance of monoclonal antibodies portfolio.

Biocon to buy 26 percent stake in AMPYR Renewable Energy Resources Eleven

AREREPL was incorporated on April 13, 2021. It is a special purpose vehicle formed for generation and supply of solar power. It will develop a 30 MWac solar power plant at Benkanhal village in Karnataka, Biocon said in a regulatory filing.

Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics

Aiming to revolutionise the cancer therapy treatment in India, Immuneel Therapeutics hopes to bring down the cost of CAR-T therapy for patients.

Biocon shares plunge 4% as bribery allegations surface against company

In a statement, Biocon denied all allegations.

All you need to know about drug regulatory framework in India and the process of drug approval

A pharmaceutical company in India must have DGCI approval for selling a new prescription drug. Different countries or blocs have separate regulatory agencies tasked with reviewing new drugs and medical devices before companies can sell them.

Top 10 trading ideas from experts for next 3-4 weeks as bears maul the markets

After a short-term correction, Dr Reddy's Laboratories has formed higher bottom reversal formation. The stock is consistently taking support near the 50 and 20 day SMA (Rs 4,192, Rs 4,227)

Trade Spotlight | What's the call on Biocon, Container Corporation, IEX?

On daily charts, IEX has formed long bullish candle which is broadly positive. But at the same time, the stock is consistently taking resistance near 20 days SMA. The medium term texture of the stock is non-directional, perhaps, traders are waiting for the either side breakout.

Kiran Mazumdar-Shaw on the poor state of Bengaluru roads: ‘Shame on local politicians’

Kiran Mazumdar-Shaw on Monday slammed the Karnataka government for the “abominable” condition of roads in the state capital.

Kiran Mazumdar-Shaw announces mother’s death: ‘She left a huge void’

Kiran Mazumdar-Shaw announced the death of her mother, Yamini Mazumdar, on Twitter.

Trust Shashi Tharoor to find an error in Kiran Mazumdar-Shaw’s post on ‘amazing’ English sentence

In her post, Kiran Mazumdar-Shaw shared an example of a rhopalic sentence - and Tharoor spotted an error.

Buy Biocon: target of Rs 420: Sharekhan

Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 420 in its research report dated April 29, 2022.